MNKD - MannKind Corporation
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.01
|
Rev Est: $99.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$9.33
DETAILS
HIGH:
$11.00
LOW:
$8.00
MEDIAN:
$9.00
CONSENSUS:
$9.33
UPSIDE:
68.41%
Market Cap:
1.70B
Volume:
1,886,970
Avg Volume:
3,405,945
52 Week Range:
3.38-6.51
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.76
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
403
IPO Date:
2004-07-28
EPS (TTM):
0.10
P/E Ratio:
63.96
Revenue (TTM):
285.50M
Total Assets:
393.84M
Total Debt:
47.70M
Cash & Equiv:
46.34M
Rev Growth (5Y):
35.3%
EPS Growth (5Y):
-27.9%
FCF Growth (5Y):
N/A
ROCE:
22.0%
Debt/Equity:
-0.61
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $0.03 | $0.01 | +200.0% | $82.1M | $99.8M | -17.7% |
| 2025-08-06 | $0.00 | $0.04 | -94.6% | $76.5M | $80.2M | -4.5% |
| 2025-05-08 | $0.04 | $0.03 | +33.3% | $78.4M | $78.4M | -0.1% |
| 2025-02-26 | $0.03 | $0.03 | 0.0% | $76.8M | $75.0M | +2.4% |
| 2024-11-07 | $0.04 | $0.06 | -33.3% | $70.1M | $74.9M | -6.4% |
| 2024-08-07 | $0.05 | $-0.03 | +249.9% | $72.4M | $64.8M | +11.7% |
| 2024-05-08 | $0.04 | $0.03 | +53.8% | $66.3M | $60.5M | +9.5% |
| 2024-02-27 | $0.02 | — | — | $58.5M | $53.6M | +9.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 285.50M | 198.96M | 99.77M | 75.44M | 65.14M | 63.04M | 27.86M | 11.74M | 174.76M | 0 | 0 | 0 |
| Net Income | 27.59M | (11.94M) | (87.40M) | (80.93M) | (57.24M) | (51.90M) | (86.97M) | (117.33M) | 125.66M | (368.44M) | (198.38M) | (191.49M) |
| EPS | 0.10 | -0.04 | -0.44 | -0.37 | -0.26 | -0.31 | -0.60 | -1.13 | 1.37 | -4.54 | -2.57 | -3.20 |
| Total Assets | 393.84M | 475.20M | 295.28M | 321.16M | 108.61M | 93.72M | 107.70M | 84.58M | 107.06M | 126.41M | 394.44M | 258.65M |
| Total Debt | 47.70M | 272.62M | 288.40M | 289.22M | 123.44M | 121.41M | 102.49M | 156.82M | 148.50M | 139.50M | 49.52M | 147.96M |
| Cash & Equivalents | 46.34M | 238.48M | 69.77M | 124.18M | 67.00M | 29.91M | 71.16M | 43.95M | 22.89M | 59.07M | 120.84M | 70.79M |
| Operating Cash Flow | 42.51M | 34.09M | (80.70M) | (61.71M) | (28.13M) | (88.48M) | (37.73M) | (64.78M) | (78.09M) | (57.23M) | 4.09M | (128.73M) |
| Free Cash Flow | 32.82M | (8.35M) | (88.29M) | (73.17M) | (32.91M) | (91.05M) | (38.09M) | (64.78M) | (79.23M) | (67.52M) | (20.01M) | (136.72M) |
| FCF per Share | 0.12 | -0.03 | -0.34 | -0.29 | -0.15 | -0.47 | -0.26 | -0.62 | -0.86 | -0.83 | -0.26 | -2.28 |
| Book Value | (78.82M) | (246.17M) | (250.54M) | (209.35M) | (180.42M) | (190.53M) | (175.08M) | (214.73M) | (183.59M) | (350.33M) | (73.77M) | (30.71M) |
| Cash & ST Investments | 197.26M | 295.10M | 170.85M | 204.12M | 67.00M | 49.88M | 71.16M | 43.95M | 22.89M | 59.07M | 120.84M | 70.79M |
| ROC Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |